0.9109USD-5.12%Mkt Cap: 942521 $P/E: —2d ago
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measureme…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap942.52K $
Enterprise Value-5.32M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.85M $
Revenue/Share—
Last Price0.9109 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.94
PEG—
EV/EBITDA0.73
EV/Revenue—
P/S—
P/B0.20
EPS (TTM)-2.22
EPS (Forward)-0.32
52W Range
0.83001% of range16.68
52W High16.68 USD
52W Low0.8300 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-114.61%
ROA-96.20%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.05M $
CapEx (TTM)173.74K $
FCF Margin—
FCF Yield-376.15%
Net Debt-9.52M $
Net Debt/EBITDA1.32
Balance Sheet
Debt/Equity0.02
Current Ratio4.64
Quick Ratio4.54
Book Value/Sh4.746 USD
Cash/Share2.148 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateJan 29, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.03M
Float2.95M
Insiders1.40%
Institutions8.33%
Short Interest
Short Ratio0.0d
Short % Float1.75%
Short % Out.1.64%
Shares Short16.98K
Short (prev mo.)455.20K
Technical
SMA 501.853 (-50.8%)
SMA 2002.756 (-66.9%)
Beta0.89
S&P 52W Chg18.16%
Avg Vol (30d)4.65M
Avg Vol (10d)446.56K
Technical Indicators
RSI (14)36.7
MACD-0.1916
MACD Signal-0.2417
MACD Hist.+0.0500
BB Upper1.213 USD
BB Middle1.022 USD
BB Lower0.8323 USD
BB Width37.19%
ATR (14)0.1893 USD
Vol Ratio (20d)0.02x